Product Information
TETRABENAZINE 25 MG TABLET is a generic product labeled by Bionpharma Inc., priced at $1.3156 per EA under NDC 69452011821. Its NADAC has been published 128 times since Jan 17, 2024.
Strength
25 mg/1
Manufacturer
Bionpharma Inc.NDC
69452011821
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TETRABENAZINEApproval Type
Generic (ANDA)
FDA Application
ANDA208826On Market Since
1/15/2018
Pharmacological Classes
Price Statistics
The NADAC for TETRABENAZINE 25 MG TABLET has been published 128 times since Jan 17, 2024, and over the history we have for it it has declined 12.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.3156 per EA |
|---|---|
| All-time high | $1.6207 (Apr 16, 2025) |
| All-time low | $1.1286 (Aug 21, 2024) |
| 52-week high | $1.4533 |
| 52-week low | $1.2014 |
| Median price | $1.3500 |
| Average price | $1.3762 |
| Largest weekly change | +29.3% (Nov 20, 2024) |
| Weeks tracked | 128 |
| Tracking since | Jan 17, 2024 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TETRABENAZINE 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TETRABENAZINE 25 MG TABLET, manufactured by Bionpharma Inc., is $1.3156 per EA (NDC 69452011821), effective Jun 24, 2026.
How has the price of TETRABENAZINE 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for TETRABENAZINE 25 MG TABLET has declined 12.2%. It has been tracked across 128 weekly CMS publications since Jan 17, 2024.
What are the highest and lowest recorded NADAC prices for TETRABENAZINE 25 MG TABLET?
Since Jan 17, 2024, the NADAC for TETRABENAZINE 25 MG TABLET has ranged from a low of $1.1286 (Aug 21, 2024) to a high of $1.6207 (Apr 16, 2025), with a median of $1.3500 per EA.
Are there cheaper alternatives to TETRABENAZINE 25 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as TETRABENAZINE 25 MG TABLET, but none are currently priced below it.
Who manufactures TETRABENAZINE 25 MG TABLET?
TETRABENAZINE 25 MG TABLET (NDC 69452011821) is labeled by Bionpharma Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification